TCM
NVAX icon

Teza Capital Management’s Novavax NVAX Stock Holding History

Teza Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,454
Closed -$110K – 221
2025
Q2 		$110K Buy
+17,454
New +$116K 0.08% 300
2024
Q4 		– Sell
-14,459
Closed -$183K – 652
2024
Q3 		$183K Buy
+14,459
New +$187K 0.02% 553

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Teza Capital Management's NVAX Position: Q3 2025 in Review

Teza Capital Management sold out of Novavax (NVAX) in Q3 2025, closing a stake of 17,454 shares — an estimated $110K sold.

Teza Capital Management first reported a position in NVAX in Q3 2024 and held it in 2 quarters. The position peaked at $183K in Q3 2024. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • Teza Capital Management reported no remaining Novavax position as of Q3 2025 after selling out during the quarter.
  • Teza Capital Management sold 17,454 Novavax shares in Q3 2025, an estimated $110K.
  • Teza Capital Management first reported a position in Novavax in Q3 2024 and held it in 2 quarters.
  • Teza Capital Management's Novavax position peaked at $183K in Q3 2024.
  • 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on Teza Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.